Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Yifat, Snir"'
Autor:
Jacob E. Ollech, Hagar Eran-Banai, Idan Goren, Tali Sharar Fischler, Irit Avni-Biron, Yifat Snir, Yelena Broitman, Shaked Cohen, Adi Friedenberg, Maor H. Pauker, Iris Dotan, Henit Yanai
Publikováno v:
Annals of Medicine, Vol 56, Iss 1 (2024)
Introduction Real-world data on tofacitinib’s effectiveness is limited and mainly retrospective or registry-based. We elected to conduct a pragmatic prospective study to assess the efficacy of tofacitinib for moderate to severe ulcerative colitis (
Externí odkaz:
https://doaj.org/article/9ed4192db3f5459abdc38b3fc00a06b6
Autor:
Hadar Edelman-Klapper, Keren Masha Rabinowitz, Eran Zittan, Ariella Bar-Gil Shitrit, Idan Goren, Irit Avni-Biron, Jacob E. Ollech, Lev Lichtenstein, Hagar Banai-Eran, Henit Yanai, Yifat Snir, Maor H. Pauker, Adi Friedenberg, Adva Levy-Barda, Yelena Broitman, Haim Ben Zvi, Tsachi-Tsadok Perets, Rami Eliakim, Revital Barkan, Sophy Goren, Dani Cohen, Iris Dotan
Publikováno v:
Vaccines, Vol 11, Iss 7, p 1263 (2023)
Vaccines are pivotal for control of the coronavirus disease (COVID-19) pandemic. Patients with inflammatory bowel diseases (IBDs) treated with antitumor necrosis factor (TNF)-α have lower serologic response after two COVID-19 vaccine doses. Data reg
Externí odkaz:
https://doaj.org/article/9af7d59e6bff4e7b8f461f8cd2945422
Autor:
Olga Maria Nardone, Yifat Snir, James Hodson, Rosanna Cannatelli, Nunzia Labarile, Keith Siau, Cesare Hassan, Henit Yanai, Iris Dotan, Subrata Ghosh, Marietta Iacucci
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 15 (2022)
Background: Advanced endoscopic technologies led to significant progress in the definition of endoscopic remission of ulcerative colitis (UC) and correlate better with histological changes, compared with standard endoscopy. However, while studies hav
Externí odkaz:
https://doaj.org/article/505cd0f67dc94be9b1b591db0522ee54
Autor:
Henit Yanai, Hadar Amir Barak, Jacob E Ollech, Irit Avni Biron, Idan Goren, Yifat Snir, Hagar Banai Eran, Yelena Broitman, Maya Aharoni Golan, Elena Didkovsky, Iris Amitay-Laish, Ayelet Ollech, Emmilia Hodak, Iris Dotan, Lev Pavlovsky
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Background and Aims: Skin eruptions are prevalent among patients with inflammatory bowel diseases (IBD), often associated with therapies and frequently leading to dermatological consults and treatment interruptions. We aimed to assess the impact of j
Externí odkaz:
https://doaj.org/article/88b32f4454734962ae309656aa9a48f8
Autor:
Keren Masha Rabinowitz, Michal Navon, Hadar Edelman-Klapper, Eran Zittan, Ariella Bar-Gil Shitrit, Idan Goren, Irit Avni-Biron, Jacob E. Ollech, Lev Lichtenstein, Hagar Banai-Eran, Henit Yanai, Yifat Snir, Maor H. Pauker, Adi Friedenberg, Adva Levy-Barda, Arie Segal, Yelena Broitman, Eran Maoz, Baruch Ovadia, Maya Aharoni Golan, Eyal Shachar, Shomron Ben-Horin, Nitsan Maharshak, Michal Mor, Haim Ben Zvi, Rami Eliakim, Revital Barkan, Tali Sharar-Fischler, Sophy Goren, Noy Krugliak, Edward Pichinuk, Michael Mor, Michal Werbner, Joel Alter, Hanan Abu-Taha, Kawsar Kaboub, Moshe Dessau, Meital Gal-Tanamy, Dani Cohen, Natalia T. Freund, Iris Dotan, on behalf of the Responses to COVID-19 Vaccine Israeli IBD Group
Publikováno v:
Vaccines, Vol 10, Iss 8, p 1186 (2022)
Patients with inflammatory bowel disease (IBD) treated with anti-tumor-necrosis factor-alpha (TNFα) exhibited lower serologic responses one-month following the second dose of the COVID-19 BNT162b2 vaccine compared to those not treated with anti-TNF
Externí odkaz:
https://doaj.org/article/002599bbb4e74664a74f8cb9e8c3051d
Autor:
Ollech, Tom Konikoff, Henit Yanai, Dror Libchik, Irit Avni-Biron, Yifat Snir, Hagar Banai, Yelena Broytman, Iris Dotan, Jacob E.
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 13; Pages: 4488
Background and Aim: Drug sustainability (DS) is a surrogate marker for treatment efficacy. We aimed to compare the DS of two main biologics used to treat moderate-to-severe ulcerative colitis (UC), infliximab (IFX) and vedolizumab (VDZ), in a real-wo
Autor:
Jacob E, Ollech, Henit, Yanai, Irit, Avni-Biron, Yifat, Snir, Hagar, Banai, Revital, Barkan, Lihi, Godny, Nir, Wasserberg, Ian, White, Iris, Dotan
Publikováno v:
American Journal of Gastroenterology. 118:367-370
Whether fecal calprotectin (FC) and quality of life (QoL) questionnaires reflect change in disease activity in patients with a J-pouch is unknown.Patients with acute pouchitis were prospectively treated with a 2-week course of antibiotics. The full P
Autor:
Lev Lichtenstein, Eran Maoz, Sophy Goren, Adva Levy-Barda, Eyal Shachar, Maya Aharoni Golan, Michal Navon, Maor H. Pauker, Baruch Ovadia, Natalia T. Freund, Arie Segal, Hadar Edelman-Klapper, Rami Eliakim, Joel Alter, Jacob E. Ollech, Hagar Banai-Eran, Keren M. Rabinowitz, Haim Ben Zvi, Revital Barkan, Michal Werbner, Idan Goren, Ariella Bar-Gil Shitrit, Yelena Broitman, Henit Yanai, Tsachi-Tsadok Perets, Yifat Snir, Noy Krugliak, Shomron Ben-Horin, Dani Cohen, Meital Gal-Tanamy, Adi Friedenberg, Irit Avni-Biron, Moshe Dessau, Iris Dotan, Eran Zittan
Publikováno v:
Gastroenterology
Background Patients with inflammatory bowel diseases (IBD), specifically those treated with anti-tumor-necrosis-factor (TNF)α biologics are at high risk for vaccine preventable infections. Their ability to mount adequate vaccine responses is unclear
Autor:
Maya Golan, Yelena Broitman, Idan Goren, Haim Leibovitzh, Henit Yanai, Shachaf Shiber, Revital Barkan, Hadar Amir-Barak, Michael Drescher, Edna Adani, Tom Konikoff, Irit Avni Biron, Yifat Snir, Iris Dotan, Hadas Steiner, Hadar Yafee, Hagar Banai Eran
Publikováno v:
Journal of Clinical Gastroenterology. 56:148-153
GOAL The aim was to assess proactive specialized inflammatory bowel diseases (IBD) emergency department (ED) consultation and multidisciplinary IBD team (IBD-MDT) intervention on IBD-related patient outcomes after discharge. BACKGROUND Despite advanc
Autor:
Marietta Iacucci, Yifat Snir
Publikováno v:
Techniques and Innovations in Gastrointestinal Endoscopy. 23:42-56
Endoscopic assessment of inflammation and mucosal healing is an important tool for the appropriate management of patients with inflammatory bowel diseases (IBD). The current definition of mucosal healing using standard white-light endoscopy is being